How to buy Dynacure (DYCU) stock when it goes public

How to buy Dynacure stock when it starts trading

1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
2. Open your brokerage account. Complete an application with your details.
3. Confirm your payment details. Fund your account.
4. Research the stock. Find the stock by name or ticker symbol – DYCU – and research it before deciding if it's a good investment for you.
5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.

Finder's picks for buying Dynacure stock when it goes public

Alternative pick for crypto trading

Go to site

• $0 commission trading
• Instant withdrawals with a 1.75% fee
• Supports 250+ cryptocurrencies
• High-yield account earns up to 4.65% APY

Disclaimer

Terms apply. Cryptoassets are highly volatile. Your capital is at risk. Available in the US, CA, UK and AU

Disclaimer: This page is not financial advice or an endorsement of digital assets, providers or services. Digital assets are volatile and risky, and past performance is no guarantee of future results. Potential regulations or policies can affect their availability and services provided. Talk with a financial professional before making a decision. Finder or the author may own cryptocurrency discussed on this page.

Top pick for advanced traders

Go to site

• Trade options, futures, options on futures, stocks, ETFs
• $0 commission to close options
• Pro-grade platform and risk analysis tools

Top pick for best mobile experience

Go to site

• Trade $0 commission stocks, ETFs, and options with as little as $1
• After-hours trading available
• Earn 4.5% interest on uninvested cash with Gold
• 24/7 customer support

How do similar companies perform?

It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy Dynacure stock.

• PPD (PPD.US)

  Company summary

  PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina. As of December 8, 2021, PPD, Inc. operates as a subsidiary of Thermo Fisher Scientific Inc.

  Historical performance

  Stock information

  • Market capitalization: $16613955584
  • P/E ratio: 47.0448
  • PEG ratio: 1.541
  • Dividend yield: N/A%

  Get more detailed information and learn how to buy PPD.US stock

• PRA Health Sciences (PRAH.US)

  Company summary

  PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that allow clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina. As of July 1, 2021, PRA Health Sciences, Inc. operates as a subsidiary of ICON Public Limited Company.

  Historical performance

  Stock information

  • Market capitalization: $10704848896
  • P/E ratio: 50.5229
  • PEG ratio: 2.0426
  • Dividend yield: 0%

  Get more detailed information and learn how to buy PRAH.US stock

• Syneos Health (SYNH.US)

  Company summary

  Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

  Historical performance

  Stock information

  • Market capitalization: $4457842688
  • P/E ratio: 61.4
  • PEG ratio: 1.2799
  • Dividend yield: 0%

  Get more detailed information and learn how to buy SYNH.US stock

Compare trading platforms

1 - 9 of 9

Name	Product USFST	Ratings	Available asset types	Stock trade fee	Minimum deposit	Cash sweep APY	Signup bonus
Tastytrade Finder Score: 4.4 / 5: ★★★★★ Tastytrade Finder Score: 4.4 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills	$0	$0	N/A	Get $50-$5,000	Competitive, capped options commissions, with a reliable trading platform designed for serious traders.	Go to siteView details	loading Fetching your data...
Robinhood Finder Score: 4.5 / 5: ★★★★★ Robinhood Finder Score: 4.5 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	4.5%	Get a free stock	Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.	Go to siteView details	loading Fetching your data...
OPTO Finder Score: 3.1 / 5: ★★★★★ OPTO Finder Score: 3.1 / 5: ★★★★★		★★★★★	Stocks, ETFs	$0	$0	N/A	Earn up to $300	AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.	Go to siteView details	loading Fetching your data...
EXCLUSIVE eToro Finder Score: 4 / 5: ★★★★★ eToro Finder Score: 4 / 5: ★★★★★	EXCLUSIVE	★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	4.9%	FINDER EXCLUSIVE: Get a guaranteed $15 bonus and $10 in free crypto	No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.	Go to siteView details	loading Fetching your data...
Public.com Finder Score: 4.3 / 5: ★★★★★ Public.com Finder Score: 4.3 / 5: ★★★★★		★★★★★	Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account	$0	$0	4.35%	Get up to $10,000 and transfer fees covered	Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.	Go to siteView details	loading Fetching your data...
Stash Finder Score: 3.7 / 5: ★★★★★ Stash Finder Score: 3.7 / 5: ★★★★★		★★★★★	Stocks, ETFs	$0	$0	0.1%	Get $10 when you sign up and deposit $5	Automated investing, individual stock and ETF investing and banking services for as low as $3 per month.	Go to siteView details	loading Fetching your data...
Wealthfront Finder Score: 4.5 / 5: ★★★★★ Wealthfront Finder Score: 4.5 / 5: ★★★★★		★★★★★	Stocks, ETFs	$0	$500	5%	Get $50	Automated stock and bond ETF investing with the ability to trade individual stocks for as little as $1 apiece.	Go to siteView details	loading Fetching your data...
Zacks Trade Finder Score: 3.8 / 5: ★★★★★ Zacks Trade Finder Score: 3.8 / 5: ★★★★★		★★★★★	Stocks, Bonds, Mutual funds, ETFs, CDs	$0.01	$250	2.83%	Get up to $500	Trade stocks, options, ETFs, mutual funds and bonds, with powerful trading tools and low margin rates.	Go to siteView details	loading Fetching your data...
M1 Finance Finder Score: 4.1 / 5: ★★★★★ M1 Finance Finder Score: 4.1 / 5: ★★★★★		★★★★★	Stocks, ETFs, Cryptocurrency	$0	$100	4.25%	N/A	Build a custom portfolio of stocks and ETFs with automatic rebalancing. Plus, earn 4.25% APY with a high-yield cash account.	Go to siteView details	loading Fetching your data...

loading